Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEN
1076
CALL
DELISTED
ZENDESK INC
ZEN
| $39.9M | 0.01% |
278,700
+19,500
| +8% | +$2.42M |
|
1077
Illinois Tool Works
ITW
$83.3B
| $39.9M | 0.01% |
195,505
-258,350
| -57% | -$52.8M |
|
1078
CALL
Phillips 66
PSX
$92.8B
| $39.8M | 0.01% |
569,200
-63,900
| -10% | -$3.75M |
|
|
LONA
1079
LeonaBio Inc
LONA
$73.9M
| $39.8M | 0.01% |
116,116
+8,314
| +8% | +$1.96M |
|
1080
CVS Health
CVS
$121B
| $39.7M | 0.01% |
581,576
-330,737
| -36% | -$21.5M |
|
1081
Kimberly-Clark
KMB
$36.8B
| $39.7M | 0.01% |
294,085
+150,438
| +105% | +$21.1M |
|
|
CMRC
1082
PUT
Commerce.com Inc Series 1
CMRC
$179M
| $39.6M | 0.01% |
617,700
+412,900
| +202% | +$33M |
|
|
1083
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $39.6M | 0.01% |
105,954
-3,049,810
| -97% | -$1.08B |
|
1084
Linde
LIN
$220B
| $39.6M | 0.01% |
150,329
-234,091
| -61% | -$57.5M |
|
|
ZNGA
1085
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $39.5M | 0.01% |
4,004,068
-2,091,301
| -34% | -$18.8M |
|
1086
MSCI
MSCI
$41.8B
| $39.4M | 0.01% |
88,286
+25,729
| +41% | +$10.1M |
|
1087
Microchip Technology
MCHP
$42.2B
| $39.4M | 0.01% |
570,748
+375,688
| +193% | +$23.4M |
|
1088
Insmed
INSM
$28.9B
| $39.4M | 0.01% |
1,183,599
-896,175
| -43% | -$32.7M |
|
1089
CALL
HCA Healthcare
HCA
$89.1B
| $39.4M | 0.01% |
239,500
-28,000
| -10% | -$4.09M |
|
|
RP
1090
DELISTED
RealPage, Inc.
RP
| $39.4M | 0.01% |
451,206
-608,981
| -57% | -$39.9M |
|
|
MNDT
1091
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $39.3M | 0.01% |
1,705,986
+1,275,075
| +296% | +$19.6M |
|
1092
O'Reilly Automotive
ORLY
$74.5B
| $39.3M | 0.01% |
1,303,530
+1,262,970
| +3,114% | +$38.1M |
|
1093
MetLife
MET
$61.4B
| $39.3M | 0.01% |
836,419
+695,624
| +494% | +$30.1M |
|
1094
PUT
Kohl's
KSS
$2.22B
| $39.2M | 0.01% |
964,400
+131,600
| +16% | +$3.83M |
|
1095
PepsiCo
PEP
$192B
| $39.2M | 0.01% |
264,372
-172,049
| -39% | -$24.5M |
|
1096
PUT
Ford
F
$55.4B
| $39.2M | 0.01% |
4,459,800
+1,455,100
| +48% | +$12.2M |
|
|
FL
1097
PUT
DELISTED
Foot Locker
FL
| $39.1M | 0.01% |
966,700
-248,500
| -20% | -$9.68M |
|
1098
American International
AIG
$39.8B
| $39.1M | 0.01% |
1,031,467
+568,227
| +123% | +$20M |
|
1099
PUT
Norwegian Cruise Line
NCLH
$8.98B
| $38.9M | 0.01% |
1,529,600
-967,800
| -39% | -$20.2M |
|
1100
PUT
TransDigm Group
TDG
$68.3B
| $38.9M | 0.01% |
62,800
+29,700
| +90% | +$16.3M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.